Atara Biotherapeutics (ATRA) vs Pelthos Therapeutics (PTHS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pelthos Therapeutics (PTHS) has outperformed Atara Biotherapeutics (ATRA) over the past year, losing 24.5% versus a loss of 40.1%. Atara Biotherapeutics is the larger company by market cap ($92.6 million vs $78.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATRA | PTHS |
|---|---|---|
| Share price | $9.23 | $20.50 |
| Market cap | $92.65M | $78.48M |
| 1-day change | -1.49% | -2.33% |
| YTD return | -48.20% | -32.29% |
| 1-year return | -40.05% | -24.47% |
| 5-year return | -97.52% | — |
| Forward P/E | 5.97 | — |
| EPS (TTM) | $-1.30 | $-27.53 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.15 | $37.50 |
| 52-week low | $3.92 | $18.19 |
| Distance from 52-week high | -51.79% | -45.33% |
| Average volume | 54.11K | 59.15K |
| Shares outstanding | 10.04M | 3.83M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PTHS has outperformed ATRA by 15.6 percentage points over the past year.
ATRA vs PTHS FAQ
Which is bigger, Atara Biotherapeutics or Pelthos Therapeutics?
Atara Biotherapeutics (ATRA) is larger, with a market capitalization of $92.65M compared with $78.48M for Pelthos Therapeutics (PTHS).
Which stock has performed better over the past year, ATRA or PTHS?
PTHS returned -24.47% over the past 12 months, compared with -40.05% for ATRA (price return, excluding dividends). Past performance does not predict future results.
Are Atara Biotherapeutics and Pelthos Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.